Skip to main content
OpenTrials
Completed

NCT Number: NCT01673763

Post-ERCP Pancreatitis Prevention by Stent Insertion

The presented study is designed to analyze the efficacy of pancreatic stent insertion in patients undergoing ERCP with accidental cannulation of the pancreatic duct.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Deptartment of Hepatobiliary Diseases Leuven University Hospitals, Leuven, Belgium

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all patients undergoing ERCP with unintended cannulation or opifiacation of main pancreatic duct
  • age > 17 years
  • signed informed consent

Exclusion criteria

  • intention to intervene main pancreatic duct
  • age < 18 years
  • pregnancy
  • absent of signed informed consent

Treatment and study plan

Stent insertion into the main pancreatic duct

Device

Stent insertion into the main pancreatic duct

Primary outcomes

  1. Incidence of post-ERCP pancreatitis

    Time frame: up to 1 week

Sponsors and collaborators

Lead sponsor

Technical University of Munich

Other

Collaborators

  • KU Leuven
  • Latvijas Universitates Medicinas
  • Northern State University, Russia

Registry information

Official study title

Study to Reduce Incidence of Post-ERCP Pancreatitis by Stent Insertion in the Main Pancreatic Duct After Unintended Cannulation of the Main Pancreatic Duct

Acronym: PEPSI

Important dates

Study start
2010
Primary completion
2016
Study completion
2017
First posted
Aug 28, 2012
Registry last updated
Oct 13, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.